These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1526 related items for PubMed ID: 28264692

  • 1. A three-component cognitive behavioural lifestyle program for preconceptional weight-loss in women with polycystic ovary syndrome (PCOS): a protocol for a randomized controlled trial.
    Jiskoot G, Benneheij SH, Beerthuizen A, de Niet JE, de Klerk C, Timman R, Busschbach JJ, Laven JS.
    Reprod Health; 2017 Mar 06; 14(1):34. PubMed ID: 28264692
    [Abstract] [Full Text] [Related]

  • 2. Lifestyle changes in women with polycystic ovary syndrome.
    Moran LJ, Hutchison SK, Norman RJ, Teede HJ.
    Cochrane Database Syst Rev; 2011 Jul 06; (7):CD007506. PubMed ID: 21735412
    [Abstract] [Full Text] [Related]

  • 3. Lifestyle changes in women with polycystic ovary syndrome.
    Moran LJ, Hutchison SK, Norman RJ, Teede HJ.
    Cochrane Database Syst Rev; 2011 Feb 16; (2):CD007506. PubMed ID: 21328294
    [Abstract] [Full Text] [Related]

  • 4. Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): A secondary analysis of a randomized controlled trial.
    Jiskoot G, Dietz de Loos A, Beerthuizen A, Timman R, Busschbach J, Laven J.
    PLoS One; 2020 Feb 16; 15(6):e0233876. PubMed ID: 32479544
    [Abstract] [Full Text] [Related]

  • 5. Dietary intake, eating behaviors, and quality of life in women with polycystic ovary syndrome who are trying to conceive.
    Turner-McGrievy G, Davidson CR, Billings DL.
    Hum Fertil (Camb); 2015 Mar 16; 18(1):16-21. PubMed ID: 24921163
    [Abstract] [Full Text] [Related]

  • 6. Improvements in PCOS characteristics and phenotype severity during a randomized controlled lifestyle intervention.
    Dietz de Loos ALP, Jiskoot G, Timman R, Beerthuizen A, Busschbach JJV, Laven JSE.
    Reprod Biomed Online; 2021 Aug 16; 43(2):298-309. PubMed ID: 34238659
    [Abstract] [Full Text] [Related]

  • 7. Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary Syndrome.
    Legro RS, Dodson WC, Kris-Etherton PM, Kunselman AR, Stetter CM, Williams NI, Gnatuk CL, Estes SJ, Fleming J, Allison KC, Sarwer DB, Coutifaris C, Dokras A.
    J Clin Endocrinol Metab; 2015 Nov 16; 100(11):4048-58. PubMed ID: 26401593
    [Abstract] [Full Text] [Related]

  • 8. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.
    Hoeger KM, Kochman L, Wixom N, Craig K, Miller RK, Guzick DS.
    Fertil Steril; 2004 Aug 16; 82(2):421-9. PubMed ID: 15302293
    [Abstract] [Full Text] [Related]

  • 9. Lifestyle changes in women with polycystic ovary syndrome.
    Lim SS, Hutchison SK, Van Ryswyk E, Norman RJ, Teede HJ, Moran LJ.
    Cochrane Database Syst Rev; 2019 Mar 28; 3(3):CD007506. PubMed ID: 30921477
    [Abstract] [Full Text] [Related]

  • 10. Benefit of Delayed Fertility Therapy With Preconception Weight Loss Over Immediate Therapy in Obese Women With PCOS.
    Legro RS, Dodson WC, Kunselman AR, Stetter CM, Kris-Etherton PM, Williams NI, Gnatuk CL, Estes SJ, Allison KC, Sarwer DB, Diamond MP, Schlaff WD, Casson PR, Christman GM, Barnhart KT, Bates GW, Usadi R, Lucidi S, Baker V, Zhang H, Eisenberg E, Coutifaris C, Dokras A.
    J Clin Endocrinol Metab; 2016 Jul 28; 101(7):2658-66. PubMed ID: 27172435
    [Abstract] [Full Text] [Related]

  • 11. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
    Ujvari D, Hulchiy M, Calaby A, Nybacka Å, Byström B, Hirschberg AL.
    Hum Reprod; 2014 Jul 28; 29(7):1526-35. PubMed ID: 24842895
    [Abstract] [Full Text] [Related]

  • 12. Serum antimüllerian hormone in response to dietary management and/or physical exercise in overweight/obese women with polycystic ovary syndrome: secondary analysis of a randomized controlled trial.
    Nybacka Å, Carlström K, Fabri F, Hellström PM, Hirschberg AL.
    Fertil Steril; 2013 Oct 28; 100(4):1096-102. PubMed ID: 23876536
    [Abstract] [Full Text] [Related]

  • 13. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.
    Huber-Buchholz MM, Carey DG, Norman RJ.
    J Clin Endocrinol Metab; 1999 Apr 28; 84(4):1470-4. PubMed ID: 10199797
    [Abstract] [Full Text] [Related]

  • 14. Cognitive-behavioral therapy improves weight loss and quality of life in women with polycystic ovary syndrome: a pilot randomized clinical trial.
    Cooney LG, Milman LW, Hantsoo L, Kornfield S, Sammel MD, Allison KC, Epperson CN, Dokras A.
    Fertil Steril; 2018 Jul 01; 110(1):161-171.e1. PubMed ID: 29908771
    [Abstract] [Full Text] [Related]

  • 15. The role of obesity in the development of polycystic ovary syndrome.
    Motta AB.
    Curr Pharm Des; 2012 Jul 01; 18(17):2482-91. PubMed ID: 22376149
    [Abstract] [Full Text] [Related]

  • 16. Resumption of ovulation in anovulatory women with PCOS and obesity is associated with reduction of 11β-hydroxyandrostenedione concentrations.
    Wang Z, Van Faassen M, Groen H, Cantineau AEP, Van Oers A, Van der Veen A, Hawley JM, Keevil BG, Kema IP, Hoek A.
    Hum Reprod; 2024 May 02; 39(5):1078-1088. PubMed ID: 38503490
    [Abstract] [Full Text] [Related]

  • 17. Heterogeneity in the responsiveness to long-term lifestyle intervention and predictability in obese women with polycystic ovary syndrome.
    Pasquali R, Gambineri A, Cavazza C, Ibarra Gasparini D, Ciampaglia W, Cognigni GE, Pagotto U.
    Eur J Endocrinol; 2011 Jan 02; 164(1):53-60. PubMed ID: 20956435
    [Abstract] [Full Text] [Related]

  • 18. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM.
    J Clin Endocrinol Metab; 2000 Aug 02; 85(8):2767-74. PubMed ID: 10946879
    [Abstract] [Full Text] [Related]

  • 19. Comparing cognitive behavioural therapy for eating disorders integrated with behavioural weight loss therapy to cognitive behavioural therapy-enhanced alone in overweight or obese people with bulimia nervosa or binge eating disorder: study protocol for a randomised controlled trial.
    Palavras MA, Hay P, Touyz S, Sainsbury A, da Luz F, Swinbourne J, Estella NM, Claudino A.
    Trials; 2015 Dec 18; 16():578. PubMed ID: 26683478
    [Abstract] [Full Text] [Related]

  • 20. The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.
    Panidis D, Tziomalos K, Papadakis E, Chatzis P, Kandaraki EA, Tsourdi EA, Katsikis I.
    Clin Endocrinol (Oxf); 2014 Mar 18; 80(3):432-8. PubMed ID: 23909452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 77.